RxDoctor Payments Data

Latrice Waddell

Psychiatric/Mental Health, Adult · Toledo, OHNPI 1316375124

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $22,640 of the $33,265 with a category attached, or 68.1%. Johnson & Johnson accounts for 80.8% of it on its own, with 14 other manufacturers making up the rest. Reporting peaked in 2023 at $25,429 and has fallen 95.7% since, to $1,082 in 2025. Among psychiatric/mental health, adult clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$33,265in general payments, 2019–2025

Across 246 payments — averaging $135.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$27K
  • Alkermes, Inc.$1K
  • AbbVie$1K
  • Otsuka America Pharmaceutical, Inc.$907
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$738
  • Axsome Therapeutics, Inc.$528
  • plus $1K from 9 others

What the payments were for

  • Speaking & faculty fees$22,64068%
  • Travel & lodging$3,0799%
  • Food & beverage$7,29322%
  • Education$2521%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$33,265 in reported general payments places this provider in the 95th percentile of 42 psychiatric/mental health, adult providers in Ohio.

See all psychiatric/mental health, adult providers in Ohio

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl12$16,627
Aripiprazole30$2,372
Bupropion XlBupropion Hcl23$578
Buspirone Hcl29$506
Oxcarbazepine20$470
Hydroxyzine Hcl15$293
Risperidone32$279
Sertraline Hcl45$254
Quetiapine Fumarate27$247
Alprazolam21$174
Venlafaxine Hcl ErVenlafaxine Hcl15$149
Escitalopram Oxalate21$120
Lamotrigine18$109
Zolpidem Tartrate11$107
Benztropine Mesylate13$102

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$1,383$16,62712 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 42 psychiatric/mental health, adult providers in Ohio.

Other psychiatric/mental health, adult in Toledo

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →